We were born in 1994 and today we are an established Italian reality in the field of production and distribution of products for health and well-being. In 2013 we become part of the Iridiem SA group, Partner of Genesis Labs. Hong Kong. Thanks to the European Patent and the Cer’8® brand, we export our products all over the world: in Italy we operate directly through networks of specialized agents in the pharmacy and large supermarket chains ; abroad we rely on selected exclusive distributors. Over the years we have established ourselves all over the world thanks to our knowledge of essential oils and their application in the field of health and well-being, on our patented patch, containing microcapsules of essential oils, and on our use of completely natural active ingredients. This experience has allowed us to work on two areas of development: Our branded products, primarily the Cer’8 anti-mosquito line present all over the world. The products that we develop on behalf of our client companies, starting from our expertise and following every production process step by step: for example, the Nau Zen anti-nausea patch by Steve Jones and the Breathe Easy balsamic patch by Sante Care Hong Kong. We have also created a division dedicated to the development of dermo-cosmetic products, Iridiem Pharma, which produces the Eriis For Hair wellness line.
| Website | https://www.laruspharma.com/ |
| Revenue | $6 million |
| Employees | 35 (13 on RocketReach) |
| Founded | 1994 |
| Address | Via Marostica, 34, Milan, Lombardy 20146, IT |
| Phone | +39 02 3310 5943 |
| Fax | +39 233611571 |
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Pharmaceutical Products, Manufacturing, Distribution, Health Products, Wellbeing Products, Nutraceuticals, Supply Chain, Dietary Supplements, Logistics, Vitamins, Minerals, Wholesale, Herbal Remedies, Health Supplements, Retail, Import Export, Personal Care Products, Wellness Products, International Trade |
| Competitors | Amgen, Regeneron, BioMarin Pharmaceutical Inc., Spark Therapeutics, Inc., CRISPR Therapeutics, CureVac, Editas Medicine, Zymeworks Inc., Sangamo Therapeutics, Inc., Akcea Therapeutics +42 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Larus Pharma employee's phone or email?
The Larus Pharma annual revenue was $6 million in 2026.
Roberto Modanesi is the CEO of Larus Pharma.
13 people are employed at Larus Pharma.
Larus Pharma is based in Milan, Lombardy.
The NAICS codes for Larus Pharma are [32, 325, 3254, 32541].
The SIC codes for Larus Pharma are [28, 283].